Online citations, reference lists, and bibliographies.

Guía ESC 2016 Sobre Prevención De La Enfermedad Cardiovascular En La Práctica Clínica

Autores, Miembros del grupo de trabajo Massimo F Piepoli, A. Hoes, Stefan Agewall, C. Albus, C. Brotons, A. L. Catapano, Marie Therese Cooney, U. Corrà, Bernard Cosyns, Christi Deaton, I. Graham, M. Hall, F. Hobbs, M. L. Løchen, H. Löllgen, P. Marques-Vidal, J. Perk, E. Prescott, J. Redon, D. J. Richter, N. Sattar, Y. Smulders, Monica Tiberi, H. B. Worp, I. Dis, W. Verschuren, Contribuidor adicional Simone Binno, Revisores del documento Guy De Backer, Marco Roffi, V. Aboyans, N. Bachl, H. Bueno, S. Carerj, Leslie Cho, John Cox, J. Sutter, G. Egidi, M. Fisher, D. Fitzsimons, O. H. Franco, M. Guenoun, C. Jennings, B. Jug, Paulus Kirchhof, K. Kotseva, G. Lip, F. Mach, G. Mancia, Franz Martín Bermudo, A. Mezzani, A. Niessner, P. Ponikowski, B. Rauch, L. Rydén, A. Stauder, G. Turc, O. Wiklund, S. Windecker, José Zamorano
Published 2016 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Las declaraciones de conflictos de intereses de los expertos participantes en el desarrollo de esta guia estan disponibles en la pagina web de la ESC: www.escardio.org/guidelines
This paper references
10.1016/S0001-4575(00)00077-4
The effects of introducing or lowering legal per se blood alcohol limits for driving: an international review.
R. Mann (2001)
10.1136/jnnp.54.12.1044
The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results.
B. Farrell (1991)
10.1093/eurheartj/eht295
Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences.
R. Chowdhury (2013)
10.1016/j.echo.2007.11.011
Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine.
J. Stein (2008)
10.1093/ehjci/jeu192
Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.
J. Plana (2014)
10.1177/1403494814557886
Psychological consequences of screening for cardiovascular risk factors in an un-selected general population: Results from the Inter99 randomised intervention study
Thomas Løkkegaard (2015)
10.1016/j.vaccine.2010.12.017
The effect of influenza vaccination on risk of acute myocardial infarction: self-controlled case-series study.
S. Gwini (2011)
Reevaluating the Rose approach: comparative benefits of the population and highrisk preventive strategies
M T Cooney (2009)
10.1097/HJH.0000000000000379
Effects of blood pressure lowering on outcome incidence in hypertension: 2. Effects at different baseline and achieved blood pressure levels – overview and meta-analyses of randomized trials
C. Thomopoulos (2014)
10.1093/PUBMED/FDH202
Predicted and observed cardiovascular disease in South Asians: application of FINRISK, Framingham and SCORE models to Newcastle Heart Project data.
R. Bhopal (2005)
10.1136/bmj.326.7394.845
Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study
B. Wilson (2003)
10.1097/HJH.0b013e328351b4e4
Longing for clinical excellence: a critical outlook into the NICE recommendations on hypertension management – is nice always good?
A. Zanchetti (2012)
Cholesterol Treatment Trialists
B Mihaylova (2012)
10.1016/S1062-1458(01)00237-9
Marital stress worsens prognosis in women with coronary heart disease: The Stockholm Female Coronary Risk Study.
K. Orth-Gomér (2000)
10.1161/CIR.0b013e31820a55f5
Forecasting the Future of Cardiovascular Disease in the United States: A Policy Statement From the American Heart Association
P. Heidenreich (2011)
Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of
Grecia: Sociedad Helena de Cardiología
10.1002/14651858.cd001561.pub2
Multiple risk factor interventions for primary prevention of coronary heart disease.
S. Ebrahim (2000)
10.1016/j.annepidem.2008.04.007
Heterogeneity in cause-specific mortality according to birthplace in immigrant men residing in Madrid, Spain.
E. Regidor (2008)
10.1177/2047487312449591
Use and effects of cardiac rehabilitation in patients with coronary heart disease: results from the EUROASPIRE III survey
K. Kotseva (2013)
10.1136/BMJ.326.7383.256
Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90 000 Swedish women
S. Darby (2003)
10.2337/DIACARE.26.3.725
The diabetes risk score: a practical tool to predict type 2 diabetes risk.
J. Lindström (2003)
10.1097/HJR.0b013e3283294b1d
EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries
K. Kotseva (2009)
10.1097/01.hjr.0000214616.14361.51
Cardiovascular disease risk factors among five major ethnic groups in Oslo, Norway: the Oslo Immigrant Health Study
Kathleen Glenday (2006)
10.1016/S0140-6736(03)13636-7
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.
R. Collins (2003)
10.1161/JAHA.113.000254
Changes in Clinical and Microbiological Periodontal Profiles Relate to Progression of Carotid Intima‐Media Thickness: The Oral Infections and Vascular Disease Epidemiology Study
M. Desvarieux (2013)
10.1097/00004045-199907000-00013
The Department of Health and Human Services.
J. Stoker (1999)
10.1097/PSY.0000000000000022
Effect of Collaborative Care for Depression on Risk of Cardiovascular Events: Data From the IMPACT Randomized Controlled Trial
J. Stewart (2014)
10.1136/bmj.c1693
Estimating the population impact of screening strategies for identifying and treating people at high risk of cardiovascular disease: modelling study
P. Chamnan (2010)
10.1161/CIRCULATIONAHA.107.181485
Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology.
P. Thompson (2007)
10.1056/NEJM200004133421502
Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy.
G. M. Felker (2000)
10.1097/PSY.0b013e3181dbff97
Prognostic Association of Anxiety Post Myocardial Infarction With Mortality and New Cardiac Events: A Meta-Analysis
A. Roest (2010)
10.1136/bmj.324.7343.939
Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies
J. Evans (2002)
10.1136/bmjopen-2012-001029
Cost-effectiveness of a European preventive cardiology programme in primary care: a Markov modelling approach
H. Mistry (2012)
10.20996/1819-6446-2005-1-3-57-65
European guidelines on cardiovascular disease prevention in clinical practice: full text
I. Graham (2005)
10.1016/S0140-6736(09)60731-5
Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis
L. Bellamy (2009)
10.1017/S1368980011002254
Fish consumption and CHD mortality: an updated meta-analysis of seventeen cohort studies.
Jusheng Zheng (2012)
10.1136/bmj.325.7375.1271
Application of Framingham risk estimates to ethnic minorities in United Kingdom and implications for primary prevention of heart disease in general practice: cross sectional population based study
F. Cappuccio (2002)
10.1370/afm.854
Absolute Cardiovascular Disease Risk and Shared Decision Making in Primary Care: A Randomized Controlled Trial
T. Krones (2008)
10.1016/J.YPMED.2007.05.014
Changes in leisure time physical activity and risk of all-cause mortality in men and women: the Baltimore Longitudinal Study of Aging.
L. Talbot (2007)
10.1136/heartjnl-2011-300747
Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review
S. Peters (2011)
10.1017/S0007114514000750
LDL-cholesterol-lowering effect of plant sterols and stanols across different dose ranges: a meta-analysis of randomised controlled studies
R. T. Ras (2014)
10.1016/S0140-6736(06)68734-5
Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial.
P. Halkes (2006)
10.1007/s00228-010-0816-3
Do immigrants from Turkey, Pakistan and Yugoslavia receive adequate medical treatment with beta-blockers and statins after acute myocardial infarction compared with Danish-born residents? A register-based follow-up study
Nana Folmann Hempler (2010)
10.1136/bmj.39261.471806.55
Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study
J. Hippisley-Cox (2007)
10.1093/ANNONC/MDS293
Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines.
G. Curigliano (2012)
10.1136/heartjnl-2014-305783
Smartphone-based home care model improved use of cardiac rehabilitation in postmyocardial infarction patients: results from a randomised controlled trial
M. Varnfield (2014)
10.1186/1471-2458-9-122
Pilot evaluation of a walking school bus program in a low-income, urban community
J. Mendoza (2009)
10.1016/j.amjcard.2013.01.303
Meta-analysis of aerobic interval training on exercise capacity and systolic function in patients with heart failure and reduced ejection fractions.
M. Haykowsky (2013)
10.1161/ATVBAHA.112.301120
Genetic Risk Prediction and a 2-Stage Risk Screening Strategy for Coronary Heart Disease
E. Tikkanen (2013)
10.1016/S0002-9149(01)02349-9
Volumetric intravascular ultrasound quantification of the amount of atherosclerosis and calcium in nonstenotic arterial segments.
A. Tinana (2002)
10.7326/0003-4819-151-6-200909150-00137
Systematic Review: Glucose Control and Cardiovascular Disease in Type 2 Diabetes
T. Kelly (2009)
10.1161/CIRCOUTCOMES.113.000264
Explaining the Decline in Coronary Heart Disease Mortality in Portugal Between 1995 and 2008
M. Pereira (2013)
10.1016/S2213-2600(15)00521-4
E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis.
Sara Kalkhoran (2016)
10.1249/MSS.0b013e31821ece12
2011 Compendium of Physical Activities: a second update of codes and MET values.
B. Ainsworth (2011)
10.1007/s10389-007-0101-9
A review of European research on consumer response to nutrition information on food labels
K. Grunert (2007)
10.1007/s10654-013-9783-1
Dietary fiber consumption and risk of stroke
Z. Zhang (2013)
10.1007/978-1-84882-185-9_5
Heart failure with preserved ejection fraction.
A. Ahmed (2006)
10.1016/S0140-6736(12)60367-5
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
Cholesterol Treatment Trialists' (CTT) Collaborato (2012)
10.1136/heartjnl-2014-305693
Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3)
Jbs Board (2014)
10.1097/00008483-200105000-00012
EFFECTS ON BLOOD PRESSURE OF REDUCED DIETARY SODIUM AND THE DIETARY APPROACHES TO STOP HYPERTENSION ( DASH ) DIET
Rank (2000)
10.1016/j.atherosclerosis.2009.02.041
HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk.
M. Cooney (2009)
Emerging Risk Factors
JM Dekker (2012)
10.1002/14651858.CD009868
Fixed-dose combination therapy for the prevention of cardiovascular disease.
Angharad N de Cates (2012)
Snus under svangerskap er ikke ufarlig. Tidsskrift for Den norske legeforening
F Gallefoss (2012)
10.1093/eurpub/ckp039
By how much would limiting TV food advertising reduce childhood obesity?
J. Veerman (2009)
10.1097/01.hjr.000116823.84388.6c
Screening for psychosocial risk factors in patients with coronary heart disease-recommendations for clinical practice
C. Albus (2004)
10.1016/j.hlc.2011.05.013
Lifestyle risk reduction interventions in atrial fibrillation: a systematic review.
N. Lowres (2011)
10.1136/jech.56.9.702
Importance of light smoking and inhalation habits on risk of myocardial infarction and all cause mortality. A 22 year follow up of 12 149 men and women in The Copenhagen City Heart Study
E. Prescott (2002)
10.1136/bmj.315.7114.973
Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence
M. Law (1997)
10.1016/S2213-8587(15)00081-9
A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys.
Kaveh Hajifathalian (2015)
10.1002/14651858.CD009009.pub2
General health checks in adults for reducing morbidity and mortality from disease.
Lasse T Krogsbøll (2012)
10.1097/00008483-200307000-00002
Leisure time physical activity of patients in maintenance cardiac rehabilitation.
J. Schairer (2003)
10.1016/S0140-6736(04)17018-9
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
S. Yusuf (2004)
10.1007/s12529-012-9282-x
Psychological Interventions for Coronary Heart Disease: Cochrane Systematic Review and Meta-analysis
B. Whalley (2012)
10.1210/jc.2012-1690
Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study.
C. Morgan (2012)
Consent: patients and doctors making decisions together. Manchester, UK: General Medical Council
(2008)
10.1093/JNCI/DJK064
Long-term risk of cardiovascular disease in 10-year survivors of breast cancer.
M. Hooning (2007)
10.1371/journal.pone.0053938
A Genome-Wide Methylation Study on Essential Hypertension in Young African American Males
X. Wang (2013)
10.1007/s10903-008-9144-4
Different Distribution of Cardiovascular Risk Factors According to Ethnicity: A Study in a High Risk Population
F. El Fakiri (2008)
10.1097/01.psy.0000174995.96183.9b
Posttraumatic Stress Disorder in the Wake of Heart Disease: Prevalence, Risk Factors, and Future Research Directions
H. Spindler (2005)
10.1016/j.amjcard.2015.02.006
Results of bococizumab, a monoclonal antibody against proprotein convertase subtilisin/kexin type 9, from a randomized, placebo-controlled, dose-ranging study in statin-treated subjects with hypercholesterolemia.
C. Ballantyne (2015)
10.1016/S0140-6736(96)09457-3
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
Caprie Steering Committee (1996)
10.1016/S0140-6736(10)60809-4
Use of mass media campaigns to change health behaviour
M. Wakefield (2010)
10.1161/CIRCULATIONAHA.109.192575
Cardiovascular Evaluation and Management of Severely Obese Patients Undergoing Surgery: A Science Advisory From the American Heart Association
P. Poirier (2009)
10.1093/eurheartj/ehq205
How to calculate vascular age with the SCORE project scales: a new method of cardiovascular risk evaluation.
J. I. Cuende (2010)
10.1080/14034940600777476
Tobacco images and texts in Norwegian magazines and newspapers
M. Løchen (2007)
ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology
DC JrGoff (2013)
Metabolite profiling and cardiovascular event risk: a prospective study of 3 populationbased cohorts. Circulation
P Wurtz (2015)
10.1093/eurheartj/ehv027
Ranking of psychosocial and traditional risk factors by importance for coronary heart disease: the Copenhagen City Heart Study.
P. Schnohr (2015)
10.3390/nu6083274
Target Salt 2025: A Global Overview of National Programs to Encourage the Food Industry to Reduce Salt in Foods
J. Webster (2014)
10.1161/HYPERTENSIONAHA.109.139816
Compliance, Safety, and Effectiveness of Fixed-Dose Combinations of Antihypertensive Agents: A Meta-Analysis
A. Gupta (2010)
10.1002/14651858.CD004148.pub4
Effectiveness of brief alcohol interventions in primary care populations.
E. Kaner (2018)
10.1136/bmj.b4531
Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials
G. de Berardis (2009)
10.1016/S0140-6736(98)07037-8
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
UK Prospective Diabetes Study Group (1998)
This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited
(2008)
10.1371/journal.pone.0059139
Internet-Delivered Cognitive Behavioural Therapy for Adults with Mild to Moderate Depression and High Cardiovascular Disease Risks: A Randomised Attention-Controlled Trial
N. Glozier (2013)
10.1016/S0140-6736(12)60312-2
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
B. F. Voight (2012)
10.1136/bmj.e6698
Association between fish consumption, long chain omega 3 fatty acids, and risk of cerebrovascular disease: systematic review and meta-analysis
R. Chowdhury (2012)
Snus under svangerskap er ikke ufarlig
F Gallefoss (2012)
10.1056/NEJMoa1305889
Alogliptin after acute coronary syndrome in patients with type 2 diabetes.
W. White (2013)
10.1016/S0140-6736(09)60503-1
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
Antithrombotic Trialists' (ATT) Collaboration (2009)
Emerging Risk Factors
S Kaptoge (2012)
10.1016/J.ACCREVIEW.2005.02.064
Risk of myocardial infarction and stroke after acute infection or vaccination.
L. Smeeth (2004)
10.1093/eurheartj/ehu033
Outbursts of anger as a trigger of acute cardiovascular events: a systematic review and meta-analysis.
E. Mostofsky (2014)
Sociedad Georgiana de Cardiología
10.1016/J.YSPM.2011.03.017
Body-Mass Index and Mortality among 1.46 Million White Adults
R. Shephard (2011)
10.1016/S0084-3741(09)79281-9
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
S. Schinner (2009)
10.1016/0002-9149(93)90155-6
Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics.
R. Williams (1993)
10.1111/ijs.12309
European Stroke Organisation (ESO) Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
T. Steiner (2014)
10.1161/CIRCULATIONAHA.108.829176
Trends in All-Cause and Cardiovascular Disease Mortality Among Women and Men With and Without Diabetes Mellitus in the Framingham Heart Study, 1950 to 2005
S. Preis (2009)
10.1371/journal.pmed.1001353
Food Pricing Strategies, Population Diets, and Non-Communicable Disease: A Systematic Review of Simulation Studies
H. Eyles (2012)
10.1159/000346087
European Stroke Organization Guidelines for the Management of Intracranial Aneurysms and Subarachnoid Haemorrhage
T. Steiner (2013)
10.3238/arztebl.2014.0320
Results of a workplace health campaign: what can be achieved?
D. Leyk (2014)
10.1186/1471-2458-6-102
Are there differences in all-cause and coronary heart disease mortality between immigrants in Sweden and in their country of birth? A follow-up study of total populations
M. Gadd (2006)
10.1200/JCO.2010.33.4730
High risk of symptomatic cardiac events in childhood cancer survivors.
Helena J. van der Pal (2012)
10.1016/J.AMEPRE.2006.08.030
Evaluation of a national physical activity intervention for children: VERB campaign, 2002-2004.
Marian Huhman (2007)
10.1136/heartjnl-2013-304474
Ethnicity and prediction of cardiovascular disease: performance of QRISK2 and Framingham scores in a UK tri-ethnic prospective cohort study (SABRE—Southall And Brent REvisited)
T. Tillin (2013)
10.1136/bmj.f6879
Dietary fibre intake and risk of cardiovascular disease: systematic review and meta-analysis
D. Threapleton (2013)
10.1136/bmj.b1665
Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies
M. Law (2009)
10.1016/j.jacc.2014.03.022
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.
C. January (2014)
10.1056/NEJMc1600827
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
M. Fischereder (2016)
10.1056/NEJMoa1501352
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
J. Green (2015)
10.1016/S2213-8587(15)00040-6
Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data.
K. Matsushita (2015)
10.1016/j.jcmg.2014.07.009
Coronary artery calcium and incident cerebrovascular events in an asymptomatic cohort. The MESA Study.
Ashleigh O Gibson (2014)
10.1161/HYP.0000000000000003
An Effective Approach to High Blood Pressure Control: A Science Advisory From the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention
A. Go (2014)
10.1093/clinchem/18.6.499
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.
W. Friedewald (1972)
10.1001/archinternmed.2011.625
Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative.
A. Culver (2012)
Exercise prescription for health-the green prescription. Dublin: RCSI House
(2013)
Joloza MT Smoking-related behaviour and attitudes
T Taylor (2005)
10.1056/NEJMoa1406656
Demographic and epidemiologic drivers of global cardiovascular mortality.
Gregory A. Roth (2015)
10.1111/j.1365-2796.2006.01644.x
Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a literature‐based meta‐analysis of prospective studies
A. Thompson (2006)
10.1001/jamainternmed.2014.739
Collaborative care for depression and anxiety disorders in patients with recent cardiac events: the Management of Sadness and Anxiety in Cardiology (MOSAIC) randomized clinical trial.
J. Huffman (2014)
10.1111/j.1479-6988.2005.00019.x
Effectiveness of nurse‐led cardiac clinics in adult patients with a diagnosis of coronary heart disease
T. Page (2005)
10.1136/bmj.323.7319.957
Randomised trials of secondary prevention programmes in coronary heart disease: systematic review
F. McAlister (2001)
10.1097/00005768-200106001-00005
Type of activity: resistance, aerobic and leisure versus occupational physical activity.
E. Howley (2001)
10.1016/J.REC.2011.11.007
ESC Guidelines on the Diagnosis and Treatment of Peripheral Artery Diseases
M. Tendera (2012)
10.1371/journal.pmed.1001321
Risk of Cardiovascular Disease and Total Mortality in Adults with Type 1 Diabetes: Scottish Registry Linkage Study
S. Livingstone (2012)
Nicotine receptor partial agonists for smoking cessation.
K. Lin (2011)
10.1001/jama.2010.221
Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial.
F. G. Fowkes (2010)
10.1007/s10654-010-9527-4
Risk of diabetes after gestational diabetes and preeclampsia. A registry-based study of 230,000 women in Norway
A. Engeland (2010)
10.1161/CIRCULATIONAHA.111.060681
Healthy Lifestyle Through Young Adulthood and the Presence of Low Cardiovascular Disease Risk Profile in Middle Age: The Coronary Artery Risk Development in (Young) Adults (CARDIA) Study
K. Liu (2012)
10.1056/NEJMsa0900459
Forecasting the effects of obesity and smoking on U.S. life expectancy.
S. Stewart (2009)
10.1002/14651858.CD001800.pub2
Exercise-based cardiac rehabilitation for coronary heart disease.
B. Heran (2011)
10.1016/J.YCAR.2012.02.090
Sports-Related Sudden Death in the General Population
C. Rowley (2012)
Sociedad Francesa de Cardiología
Nedogoda
World Health Organization. Scaling up action agains noncommunicable diseases: how much will it cost? Geneva: World Health Organization
(2011)
10.1056/NEJMRA054035
Trans fatty acids and cardiovascular disease.
D. Mozaffarian (2006)
10.1007/s10654-013-9876-x
Dietary fiber intake and risk of type 2 diabetes: a dose–response analysis of prospective studies
B. Yao (2013)
10.1136/bmj.g3617
Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial
T. Jørgensen (2014)
10.1714/1264.13965
[Population-level changes to promote cardiovascular health].
T. Jørgensen (2012)
10.1161/CIRCULATIONAHA.109.891523
Association of Diet, Exercise, and Smoking Modification With Risk of Early Cardiovascular Events After Acute Coronary Syndromes
C. Chow (2010)
10.1177/2047487312460484
Aerobic exercise intensity assessment and prescription in cardiac rehabilitation: a joint position statement of the European Association for Cardiovascular Prevention and Rehabilitation, the American Association of Cardiovascular and Pulmonary Rehabilitation and the Canadian Association of Cardiac R
A. Mezzani (2013)
10.1161/CIRCULATIONAHA.115.019634
Varenicline for Smoking Cessation in Hospitalized Patients With Acute Coronary Syndrome
M. Eisenberg (2016)
Investigators V. Glucose control and vascular complications in veterans with type 2 diabetes
W Duckworth (2009)
Documento descargado de http://www.revespcardiol.org el 14/05/2017. Copia para uso personal, se prohíbe la transmisión de este documento por cualquier medio o formato
AL Culver (2012)
10.1161/STR.0000000000000024
Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.
W. Kernan (2014)
10.3945/ajcn.2010.29673
Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis.
F. Sofi (2010)
10.1016/s0021-9150(98)00200-7
Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group.
(1999)
10.1097/HJR.0b013e32833bo969
Cardiovascular evaluation of middle-aged/senior individuals engaged in leisure-time sport activities: position stand from the sections of exercise physiology and sports cardiology of the European Association of Cardiovascular Prevention and Rehabilitation
M. Borjesson (2011)
10.1161/CIRCULATIONAHA.110.010710
Dose Response Between Physical Activity and Risk of Coronary Heart Disease: A Meta-Analysis
J. Sattelmair (2011)
10.1161/ATVBAHA.113.301218
Multilocus Genetic Risk Scores for Coronary Heart Disease Prediction
A. Ganna (2013)
10.1001/jama.2013.279206
Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis.
J. Udell (2013)
10.1016/S0140-6736(11)60679-X
National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants
G. Danaei (2011)
10.1038/sj.jhh.1001459
Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health
F J He (2002)
10.1161/CIRCULATIONAHA.111.055269
Statins and Intracerebral Hemorrhage: Collaborative Systematic Review and Meta-Analysis
D. Hackam (2011)
10.1136/bmj.322.7285.531
Blood pressure measuring devices: recommendations of the European Society of Hypertension
E. O'brien (2001)
10.1016/J.JPSYCHORES.2006.11.010
Effects of a home-based intervention program on anxiety and depression 6 months after coronary artery bypass grafting: a randomized controlled trial.
Irene Lie (2007)
10.1097/EDE.0b013e3181f20457
Ischemic Heart Disease and Stroke in Relation to Blood DNA Methylation
A. Baccarelli (2010)
10.1161/CIRCULATIONAHA.108.783944
Impact of a Prescription Copayment Increase on Lipid-Lowering Medication Adherence in Veterans
J. Doshi (2009)
10.1016/S0140-6736(12)60994-5
Job strain as a risk factor for coronary heart disease: a collaborative meta-analysis of individual participant data
M. Kivimäki (2012)
10.1161/CIRCULATIONAHA.111.065490
Association Between Family History and Coronary Heart Disease Death Across Long-Term Follow-Up in Men: The Cooper Center Longitudinal Study
J. Bachmann (2012)
10.1001/archinte.1992.00400190110021
Serum Cholesterol Level and Mortality Findings for Men Screened in the Multiple Risk Factor Intervention Trial
J. Neaton (1992)
10.1016/S0140-6736(14)61745-1
Smart food policies for obesity prevention
C. Hawkes (2015)
10.1016/S0140-6736(12)60572-8
Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study
M. Tonelli (2012)
10.1161/HYPERTENSIONAHA.113.00911
Treatment of Hypertension in the Oldest Old: A Critical Role for Frailty?
M. Muller (2014)
10.1016/j.ypmed.2014.10.009
A systematic review of health effects of electronic cigarettes.
C. Pisinger (2014)
10.1056/NEJMoa0801317
Telmisartan, ramipril, or both in patients at high risk for vascular events.
S. Yusuf (2008)
10.1016/J.ATHEROSCLEROSIS.2005.03.017
Associations between IgG antibody to oral organisms and carotid intima-medial thickness in community-dwelling adults.
J. Beck (2005)
10.1093/oxfordjournals.aje.a116294
Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study.
F. G. Fowkes (1992)
10.1093/eurheartj/ehs215
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.
P. Steg (2012)
10.1002/14651858.CD003041.PUB2/ABSTRACT
Smoking cessation for the secondary prevention of coronary heart disease.
J. Critchley (2004)
10.1161/HC0302.102575
Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) Study
G. Assmann (2002)
10.1161/HYPERTENSIONAHA.114.04273
Prognostic Value of Microalbuminuria During Antihypertensive Treatment in Essential Hypertension
J. M. Pascual (2014)
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebocontrolled trial
HM Colhoun (2004)
10.1097/PSY.0b013e318291d798
A Meta-Analysis of Mental Health Treatments and Cardiac Rehabilitation for Improving Clinical Outcomes and Depression Among Patients With Coronary Heart Disease
T. Rutledge (2013)
10.1056/NEJMoa0810177
Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.
B. Fellström (2009)
10.1016/j.ypmed.2013.06.032
The effectiveness of workplace dietary modification interventions: a systematic review.
F. Geaney (2013)
10.1001/jama.2014.18574
Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis.
C. Emdin (2015)
10.3399/bjgp11X567126
Ethnic differences in blood pressure monitoring and control in south east London.
P. Schofield (2011)
10.1136/bmj.g4164
Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data
M. Holmes (2014)
10.3399/bjgp11X572454
Cardiovascular multimorbidity: the effect of ethnicity on prevalence and risk factor management.
R. Mathur (2011)
10.1056/NEJMoa1200933
Vorapaxar in the secondary prevention of atherothrombotic events.
D. Morrow (2012)
10.1056/NEJMc1602668
A Randomized Trial of Intensive versus Standard Blood-Pressure Control.
Hai-long Dai (2016)
10.1111/obr.12002
Assessing the potential effectiveness of food and beverage taxes and subsidies for improving public health: a systematic review of prices, demand and body weight outcomes.
L. Powell (2013)
10.1177/2047487312462824
Lifestyle modification programmes for patients with coronary heart disease: a systematic review and meta-analysis of randomized controlled trials
V. Janssen (2013)
10.1016/j.jpsychires.2013.07.011
Schizophrenia and the risk of cardiovascular diseases: a meta-analysis of thirteen cohort studies.
Z. Fan (2013)
10.4045/tidsskr.12.0216
Use of snus during pregnancy is not without risk.
M. Løchen (2012)
10.1097/00008483-199405000-00008
Various intensities of leisure time physical activity in patients with coronary artery disease: effects on cardiorespiratory fitness and progression of coronary atherosclerotic lesions.
R. Hambrecht (1993)
10.1056/NEJMOA011258
A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke.
J. Mohr (2001)
10.1186/1745-6215-8-21
Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins
G. de Berardis (2007)
10.1093/JN/136.10.2588
Fruit and vegetable consumption and risk of coronary heart disease: a meta-analysis of cohort studies.
L. Dauchet (2006)
10.1016/J.YEND.2012.05.028
Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins: A Meta-analysis
P. Toth (2012)
10.1002/14651858.CD008465.pub2
Exercise interventions on health-related quality of life for people with cancer during active treatment.
S. Mishra (2012)
10.1038/jhh.2015.15
Obstructive sleep apnea, hypertension and cardiovascular diseases
C. Gonzaga (2015)
10.1161/CIRCULATIONAHA.109.873232
The polypill in the prevention of cardiovascular diseases: key concepts, current status, challenges, and future directions.
E. Lonn (2010)
10.1016/0021-9150(94)90200-3
Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension.
K. Pyörälä (1994)
10.1161/CIRCOUTCOMES.112.966903
Prediction of Cardiovascular Events and All-Cause Mortality With Erectile Dysfunction: A Systematic Review and Meta-Analysis of Cohort Studies
C. Vlachopoulos (2013)
10.1136/bmj.g4356
Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance
S. Rabar (2014)
10.1056/NEJM199901073400103
Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group.
D. O'leary (1999)
Document downloaded from http://www.revespcardiol.org/, day 06/02/2020. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited
AL Culver (2012)
10.1136/bmj.b4220
Effect of tailored practice and patient care plans on secondary prevention of heart disease in general practice: cluster randomised controlled trial
A. Murphy (2009)
Effectiveness of general practicebased health checks: a systematic review and meta-analysis
S Si (2014)
Emerging Risk Factors
N Sarwar (2010)
10.1161/CIR.0b013e3181e8edf1
Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the American Heart Association.
N. Artinian (2010)
10.1136/bmj.d671
Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis
P. Ronksley (2011)
10.1016/j.jacc.2013.05.019
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
C. Yancy (2013)
10.1002/14651858.cd003075.pub2
Treatment of hypertension in peripheral arterial disease.
D. Lane (2009)
10.1093/eurjhf/hfr017
Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation
M. Piepoli (2011)
10.1097/EDE.0b013e31821d1096
Diabetes Prevalence in Populations of South Asian Indian and African Origins: A Comparison of England and The Netherlands
C. Agyemang (2011)
10.1161/CIRCULATIONAHA.106.637793
Triglycerides and the Risk of Coronary Heart Disease: 10 158 Incident Cases Among 262 525 Participants in 29 Western Prospective Studies
N. Sarwar (2007)
10.1097/HJR.0b013e32832a4e7a
Telehealth interventions for the secondary prevention of coronary heart disease: a systematic review
L. Neubeck (2009)
AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology
R H Eckel (2013)
World Health Organisation.WHO Global Health Repository. Cardiovascular diseases, deaths per 100 000
10.1016/S2213-8587(15)00316-2
Relation of active, passive, and quitting smoking with incident type 2 diabetes: a systematic review and meta-analysis.
A. Pan (2015)
10.3399/bjgp10X482095
Effectiveness of nurse-delivered cardiovascular risk management in primary care: a randomised trial.
H. Voogdt-Pruis (2010)
10.1093/ije/dyr112
Domains of physical activity and all-cause mortality: systematic review and dose-response meta-analysis of cohort studies.
G. Samitz (2011)
10.1016/j.pcad.2013.09.002
Fitness vs. fatness on all-cause mortality: a meta-analysis.
V. Barry (2014)
10.1016/j.ypmed.2008.12.010
Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study.
T. Jørgensen (2009)
10.1056/NEJMoa1501031
Efficacy and safety of alirocumab in reducing lipids and cardiovascular events.
J. Robinson (2015)
10.1056/NEJM199511023331807
Nicotine medications for smoking cessation.
J. Henningfield (1995)
Cholesterol Treatment Trialists
PM Kearney (2008)
Active and passive smoking and the risk of myocardial infarction in 24,968 men and women during 11 year of follow-up: the Tromso Study
B Iversen (2013)
10.1177/2047487312443485
Effect of including nonfatal events in cardiovascular risk estimation, illustrated with data from The Netherlands
I. van Dis (2014)
10.1002/14651858.CD001820.PUB3
Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
E. De Schryver (2007)
10.1056/NEJMoa1209825
Risk of ischemic heart disease in women after radiotherapy for breast cancer.
S. Darby (2013)
10.1161/HC0302.102610
Morphological Predictors of Arterial Remodeling in Coronary Atherosclerosis
A. Burke (2002)
Blood pressurelowering treatment based on cardiovascular risk: a meta-analysis of individual patient data
J Sundstrom (2014)
10.1007/s00125-014-3303-z
Impact of different training modalities on glycaemic control and blood lipids in patients with type 2 diabetes: a systematic review and network meta-analysis
L. Schwingshackl (2014)
10.1001/jama.2014.16425
Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010.
S. Livingstone (2015)
Emerging Risk Factors
E Di Angelantonio (2000)
10.1016/j.annemergmed.2007.07.003
High-dose atorvastatin after stroke or transient ischemic attack.
J. Farmer (2007)
10.1056/NEJM199903253401204
Passive smoking and the risk of coronary heart disease--a meta-analysis of epidemiologic studies.
J. He (1999)
10.1136/hrt.2007.122044
Trends for coronary heart disease and stroke mortality among migrants in England and Wales, 1979–2003: slow declines notable for some groups
S. Harding (2007)
Copia para uso personal, se prohíbe la transmisión de este documento por cualquier medio o formato
AL Culver (2012)
Copia para uso personal, se prohíbe la transmisión de este documento por cualquier medio o formato. Artículo especial
(2016)
10.1093/eurheartj/ehu204
New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes.
M. Senni (2014)
10.1016/S1885-5857(09)60059-1
[ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012].
J. J. V. McMurray (2012)
10.1007/s12160-011-9339-0
Association Between Type D Personality and Prognosis in Patients with Cardiovascular Diseases: a Systematic Review and Meta-analysis
G. Grande (2012)
10.1016/S0195-668X(03)00114-3
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.
R. Conroy (2003)
10.1161/01.CIR.0000133317.49796.0E
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
S. Grundy (2004)
Health Improvement and Protection. Stay Active: A report on physical activity for health from the four home countries' Chief Medical Officers
10.1186/1471-2296-14-36
Implementation of Spanish adaptation of the European guidelines on cardiovascular disease prevention in primary care
C. Brotons (2013)
10.1016/S1522-1865(98)00012-2
Is the pathology of radiation injury different in small vs large blood vessels?
L. Fajardo (1999)
10.1093/eurheartj/ehq386
Lipoprotein(a) as a cardiovascular risk factor: current status
B. Nordestgaard (2010)
10.1016/j.jcmg.2008.11.015
Prognostic value of coronary computed tomographic angiography for prediction of cardiac events in patients with suspected coronary artery disease.
M. Hadamitzky (2009)
10.1002/14651858.CD007130.pub3
Home-based versus centre-based cardiac rehabilitation.
R. Taylor (2015)
10.1016/S0140-6736(08)61076-4
Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study
M. McQueen (2008)
10.1016/0002-8703(91)90861-B
Cardiovascular disease risk profiles.
K. M. Anderson (1991)
10.1136/ard.2009.113696
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
M. Peters (2010)
10.1016/S0140-6736(07)60108-1
Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis
W. Elliott (2007)
10.1016/S0140-6736(12)60441-3
Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data
M. Lorenz (2012)
10.1001/jama.2015.7008
Association of Cardiometabolic Multimorbidity With Mortality.
E. Di Angelantonio (2015)
Bureau Europe'en des Unions de Consommateurs. The consumer case for EU legal restrictions on the use of artificial trans-fats in food
(2014)
10.1161/01.cir.0000437738.63853.7a
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
N. Stone (2014)
10.1001/jama.2009.1619
Major lipids, apolipoproteins, and risk of vascular disease.
E. Di Angelantonio (2009)
10.1136/bmj.39147.604896.55
Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP)
N. Cook (2007)
10.1161/CIRCOUTCOMES.111.961573
Community Outreach and Cardiovascular Health (COACH) Trial: A Randomized, Controlled Trial of Nurse Practitioner/Community Health Worker Cardiovascular Disease Risk Reduction in Urban Community Health Centers
J. Allen (2011)
10.1016/S0140-6736(14)61121-1
Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial
P. Bath (2015)
10.1056/NEJMoa1107477
C-reactive protein, fibrinogen, and cardiovascular disease prediction.
S. Kaptoge (2012)
10.1016/j.ypmed.2014.04.007
Improving long-term prediction of first cardiovascular event: the contribution of family history of coronary heart disease and social status.
G. Veronesi (2014)
10.1097/YCO.0b013e328329ed75
Global alcohol policy and the alcohol industry
P. Anderson (2009)
10.1016/S0140-6736(10)62302-1
Rapid mortality falls after risk-factor changes in populations
S. Capewell (2011)
10.1007/s10654-012-9704-8
Use of snus and acute myocardial infarction: pooled analysis of eight prospective observational studies
Jenny Hansson (2012)
10.1016/j.ahj.2013.07.031
Posttraumatic stress disorder and risk for coronary heart disease: a meta-analytic review.
D. Edmondson (2013)
10.1056/NEJMOA0706482
Prasugrel versus clopidogrel in patients with acute coronary syndromes.
S. Wiviott (2007)
10.1161/CIRCULATIONAHA.113.004042
Temporal Trends in Ischemic Heart Disease Mortality in 21 World Regions, 1980 to 2010: The Global Burden of Disease 2010 Study
A. Moran (2014)
10.1001/jama.2014.16107
Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality.
T. Orchard (2015)
10.1016/j.jval.2014.03.1722
An economic evaluation of salt reduction policies to reduce coronary heart disease in England: a policy modeling study.
M. Collins (2014)
10.1056/NEJMc090911
Rehospitalizations among patients in the Medicare fee-for-service program.
E. Rackow (2009)
Scottish Intercollegiate Guidelines Network. Risk estimation and the prevention of cardiovascular disease. A national clinical guideline. Edinburgh: Scottish Intercollegiate Guidelines Network
(2007)
10.1001/JAMA.295.13.JPC60002
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.
S. Nissen (2006)
10.1161/CIRCGENETICS.108.833392
Prediction of Cardiovascular Disease Outcomes and Established Cardiovascular Risk Factors by Genome-Wide Association Markers
J. Ioannidis (2009)
10.1055/s-0028-1128150
Physical activity and all-cause mortality: an updated meta-analysis with different intensity categories.
H. Löllgen (2009)
10.1001/archinternmed.2011.2
Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors.
S. Wannamethee (2011)
10.1093/humupd/dmq001
Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis.
L. Moran (2010)
10.1016/j.jacc.2008.11.044
The association of anger and hostility with future coronary heart disease: a meta-analytic review of prospective evidence.
Y. Chida (2009)
10.7326/0003-4819-157-11-201212040-00538
Interventions to Improve Adherence to Self-administered Medications for Chronic Diseases in the United States
M. Viswanathan (2012)
10.1016/S0140-6736(09)60697-8
Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials
K. Ray (2009)
CAROTID-ARTERY INTIMA AND MEDIA THICKNESS AS A RISK FACTOR FOR MYOCARDIAL INFARCTION AND STROKE IN OLDER ADULTS
Aniel (2000)
10.1001/archinternmed.2010.510
Randomized controlled trial of cognitive behavioral therapy vs standard treatment to prevent recurrent cardiovascular events in patients with coronary heart disease: Secondary Prevention in Uppsala Primary Health Care project (SUPRIM).
Mats Gulliksson (2011)
How much does HDL cholesterol add to risk estimation? A report from the SCORE Investigators
MT Cooney (2009)
Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the
J H Lichtman (2014)
Document downloaded from http://www.revespcardiol.org/, day 16/08/2019. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited
JS (2012)
10.1016/j.atherosclerosis.2012.05.035
A genetic risk score based on direct associations with coronary heart disease improves coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC), but not in the Rotterdam and Framingham Offspring, Studies.
A. Brautbar (2012)
10.1542/peds.2013-3219
Effects of the FITKids Randomized Controlled Trial on Executive Control and Brain Function
C. Hillman (2014)
Statinassociated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
ES Stroes (2015)
10.1001/archinte.168.20.2194
Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network.
P. Giannuzzi (2008)
10.1136/bmjopen-2013-003485
Changes in cardiovascular risk factors in relation to increasing ethnic inequalities in cardiovascular mortality: comparison of cross-sectional data in the Health Surveys for England 1999 and 2004
R. Bhopal (2013)
10.1136/jnnp-2014-307856
Degree of blood pressure reduction and recurrent stroke: the PROGRESS trial
H. Arima (2014)
10.1161/CIRCULATIONAHA.106.678342
Chronic Kidney Disease: Effects on the Cardiovascular System
E. Schiffrin (2007)
10.1056/NEJMoa0806182
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.
K. Jamerson (2008)
10.1161/CIRCULATIONAHA.107.699579
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
R. D'Agostino (2008)
10.7326/M13-2266
Routine Echocardiography Screening for Asymptomatic Left Ventricular Dysfunction in Childhood Cancer Survivors: A Model-Based Estimation of the Clinical and Economic Effects
J. Yeh (2014)
Key performance indicators: findings from the Smoking Toolkit Study
R West
10.1056/NEJMoa1107579
Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.
W. Boden (2011)
[Concomitant use of statins and cytochrome P 450 inhibitors in Croatia].
Ž. Reiner (2005)
10.1016/J.AMJCARD.2006.12.065
Left ventricular architecture and survival in African-Americans free of coronary heart disease (from the Atherosclerosis Risk in Communities [ARIC] study).
H. Taylor (2007)
10.1016/j.ahj.2010.10.019
A systematic review of event rates in clinical trials in diabetes mellitus: the importance of quantifying baseline cardiovascular disease history and proteinuria and implications for clinical trial design.
D. Preiss (2011)
10.1161/CIRCULATIONAHA.111.068064
Incidence and Prognosis of Resistant Hypertension in Hypertensive Patients
Stacie L Daugherty (2012)
10.1136/bmj.326.7393.793
Effectiveness of counselling patients on physical activity in general practice: cluster randomised controlled trial
C. Elley (2003)
10.1016/j.amepre.2013.06.017
Financial incentives for exercise adherence in adults: systematic review and meta-analysis.
Marc S Mitchell (2013)
10.1200/JCO.2008.16.6546
Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy.
G. Smith (2008)
10.1016/j.jacc.2009.10.061
Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis.
C. Vlachopoulos (2010)
10.1016/S0140-6736(10)61350-5
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
Cholesterol Treatment Trialists' (CTT) Collaborati (2010)
10.1097/HJR.0b013e32833f3aa5
Exercise intolerance in chronic heart failure: mechanisms and therapies. Part II
M. Piepoli (2010)
10.7326/0003-4819-151-7-200910060-00008
Using nontraditional risk factors in coronary heart disease risk assessment: U.S. Preventive Services Task Force recommendation statement.
Ned Calonge (2009)
10.1016/S0140-6736(09)61965-6
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
N. Sattar (2010)
10.1161/01.cir.0000437741.48606.98
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
D. Goff (2014)
10.1161/01.HYP.0000215363.69793.bb
Long-Term Risk of Mortality Associated With Selective and Combined Elevation in Office, Home, and Ambulatory Blood Pressure
G. Mancia (2006)
10.1016/j.aprim.2012.10.003
[Cardiovascular risk of immigrants living in Spain according to origin and years of stay].
María Luisa Lozano Sánchez (2013)
10.5694/J.1326-5377.2008.TB01932.X
Feasibility of conducting a primary prevention trial of low-dose aspirin for major adverse cardiovascular events in older people in Australia: results from the ASPirin in Reducing Events in the Elderly (ASPREE) pilot study.
M. Nelson (2008)
10.1097/HJH.0000000000000380
Effects of blood pressure lowering on outcome incidence in hypertension: 3. Effects in patients at different levels of cardiovascular risk – overview and meta-analyses of randomized trials
C. Thomopoulos (2014)
10.1016/j.ijcard.2014.02.026
Bariatric surgery and its impact on cardiovascular disease and mortality: a systematic review and meta-analysis.
C. Kwok (2014)
10.1016/S0749-4041(10)79320-9
Major Lipids, Apolipoproteins, and Risk of Vascular Disease
G. Moneta (2010)
10.1161/HYPERTENSIONAHA.109.141879
Measurement of blood pressure in the office: recognizing the problem and proposing the solution.
M. Myers (2010)
10.1093/eurheartj/ehr112
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
M. Chapman (2011)
10.1056/NEJMoa0904327
Ticagrelor versus clopidogrel in patients with acute coronary syndromes.
L. Wallentin (2009)
10.1016/S0140-6736(08)60868-5
Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial
D. Wood (2008)
10.1056/NEJMoa1500857
Long-term use of ticagrelor in patients with prior myocardial infarction.
Marc P. Bonaca (2015)
A Review Of Research Into The Impacts Of Alcohol Warning Labels On Attitudes And Behaviour
T. Stockwell (2006)
10.1093/eurheartj/ehp546
Risk prediction is improved by adding markers of subclinical organ damage to SCORE.
T. Sehestedt (2010)
All-cause mortality risk of metabolically healthy abdominal obese individuals: the EPICMORGEN study
A D Van Der (2014)
939.e1-e87 e63 settings: a publication by the academy of psychosomatic medicine research and evidence-based practice committee
(2014)
Study of Cardiovascular Events in Diabetes
Ascend
Preventive Services Task Force. Guide to Clinical Preventive Services
(1996)
10.1093/eurheartj/ehr080
Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study
J. Banegas (2011)
10.1177/1741826711423217
Ethnic variations in the incidence and mortality of stroke in the Scottish Health and Ethnicity Linkage Study of 4.65 million people
R. Bhopal (2012)
10.1056/NEJMoa1203034
A trial of sugar-free or sugar-sweetened beverages and body weight in children.
J. C. de Ruyter (2012)
10.1093/occmed/kqu088
The Oxford Handbook of Health Communication, Behavior Change, and Treatment Adherence
N. Williams (2014)
10.3945/ajcn.110.004622
The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010?
A. Astrup (2011)
10.1136/THORAX.58.6.464
Nicotine replacement therapy in smoking cessation.
I. Campbell (2003)
10.1136/bmj.326.7404.1419
A strategy to reduce cardiovascular disease by more than 80%
N. Wald (2003)
10.1371/journal.pone.0040922
Genetic Markers Enhance Coronary Risk Prediction in Men: The MORGAM Prospective Cohorts
M. Hughes (2012)
Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes : a randomised placebo-controlled trial
10.1177/2047487315569401
EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries
K. Kotseva (2016)
Documento descargado de http://www.revespcardiol.org el 04/11/2016. Copia para uso personal, se prohíbe la transmisión de este documento por cualquier medio o formato
AL Culver (2012)
10.1016/j.jacc.2009.03.095
Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy.
D. Cardinale (2010)
10.1097/RTI.0b013e31824752bd
Population Screening for Coronary Artery Calcification Does Not Increase Mental Distress and the Use of Psychoactive Medication
A. D. Nielsen (2012)
10.1093/europace/euq350
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).
A. J. Camm (2010)
Coronary artery calcium and incident cerebrovascular events in an asymptomatic cohort
AO Gibson (2014)
National Institute for Health and Clinical Excellence (NICE) public health intervention guidance physical activity: BA for adults in primary care
F BLCampbell (2012)
10.2165/11539150-000000000-00000
The Cost Effectiveness of Statin Therapies in Spain in 2010, after the Introduction of Generics and Reference Prices
P. Plans-Rubió (2010)
10.1249/MSS.0b013e31826beae5
Sustained and shorter bouts of physical activity are related to cardiovascular health.
N. Glazer (2013)
10.1016/S0021-9150(00)00598-0
Coronary atherosclerosis in unheralded sudden coronary death under age 50: histo-pathologic comparison with 'healthy' subjects dying out of hospital.
A. Schmermund (2001)
10.1001/2012.jama.11374
Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis.
E. Rizos (2012)
10.1111/ijs.12235
Statistical analysis plan for the ‘Efficacy of Nitric Oxide in Stroke’ (ENOS) trial
P. Bath (2014)
10.1161/CIRCULATIONAHA.106.666594
Regression of Electrocardiographic Left Ventricular Hypertrophy During Antihypertensive Therapy and Reduction in Sudden Cardiac Death: The LIFE Study
K. Wachtell (2007)
10.1136/bmj.g3656
Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States
B. Schöttker (2014)
10.1016/j.jacc.2012.07.068
Incidence of heart failure or cardiomyopathy after adjuvant trastuzumab therapy for breast cancer.
J. Chen (2012)
10.1161/CIRCULATIONAHA.111.059022
Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) Randomized, Multicenter Study
H. C. Gwon (2012)
10.1002/ana.21742
Periodontitis and incidence of cerebrovascular disease in men
M. Jiménez (2009)
10.1016/j.jacc.2014.04.058
Leisure-time running reduces all-cause and cardiovascular mortality risk.
D. Lee (2014)
10.1161/CIRCULATIONAHA.106.675041
Superior Cardiovascular Effect of Aerobic Interval Training Versus Moderate Continuous Training in Heart Failure Patients: A Randomized Study
U. Wisløff (2007)
10.1002/14651858.CD010216.pub2
Electronic cigarettes for smoking cessation and reduction.
H. Mcrobbie (2014)
10.1093/infdis/jis597
Influenza Infection and Risk of Acute Myocardial Infarction in England and Wales: A CALIBER Self-Controlled Case Series Study
C. Warren-Gash (2012)
10.1001/ARCHINTE.167.6.540
Interventions to enhance medication adherence in chronic medical conditions: a systematic review.
S. Kripalani (2007)
10.1136/bmj.308.6921.81
Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
R. Altman (1994)
10.1136/bmj.c785
Effect of school based physical activity programme (KISS) on fitness and adiposity in primary schoolchildren: cluster randomised controlled trial
S. Kriemler (2010)
10.1161/CIR.0b013e318260a20b
Population Approaches to Improve Diet, Physical Activity, and Smoking Habits: A Scientific Statement From the American Heart Association
D. Mozaffarian (2012)
10.1111/j.1360-0443.1991.tb01879.x
The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.
T. Heatherton (1991)
10.1016/j.jacc.2015.07.066
Implications of Coronary Artery Calcium Testing Among Statin Candidates According to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis).
K. Nasir (2015)
10.1111/j.1360-0443.2008.02438.x
Effects of beverage alcohol price and tax levels on drinking: a meta-analysis of 1003 estimates from 112 studies.
A. Wagenaar (2009)
10.1371/journal.pone.0029849
Lack of Effect of Lowering LDL Cholesterol on Cancer: Meta-Analysis of Individual Data from 175,000 People in 27 Randomised Trials of Statin Therapy
J. Emberson (2012)
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee
M. Dennis (1996)
10.1097/01.hcr.0000281778.10468.d8
EXERCISE AND ACUTE CARDIOVASCULAR EVENTS: PLACING THE RISKS INTO PERSPECTIVE: A SCIENTIFIC STATEMENT FROM THE AMERICAN HEART ASSOCIATION COUNCIL ON NUTRITION, PHYSICAL ACTIVITY, AND METABOLISM AND THE COUNCIL ON CLINICAL CARDIOLOGY
S. Kalra (2007)
939.e1-e87 individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial
(2008)
All-cause mortality risk of metabolically healthy abdominal obese individuals: the EPICMORGEN study. Obesity. 2014;22:557–64
AD van der (2016)
10.1001/archinte.151.9.1769
Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials.
K. Radack (1991)
10.1056/NEJMoa1003955
Collaborative care for patients with depression and chronic illnesses.
W. Katon (2010)
10.1001/jama.2009.454
Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial.
C. O'Connor (2009)
10.1136/bmjopen-2013-004549
Salt reduction in England from 2003 to 2011: its relationship to blood pressure, stroke and ischaemic heart disease mortality
F. He (2014)
10.1001/archinte.152.7.1490
Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.
J. Neaton (1992)
10.1001/jamainternmed.2015.0289
Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial.
J. Kutner (2015)
National Institute for Health and Care Excellence.
M. Cowie (2015)
10.1016/j.ijcard.2013.08.046
Incidence of acute myocardial infarction in first and second generation minority groups: does the second generation converge towards the majority population?
A. V. van Oeffelen (2013)
10.2337/dc05-2465
Effect of Lowering LDL Cholesterol Substantially Below Currently Recommended Levels in Patients With Coronary Heart Disease and Diabetes
J. Shepherd (2006)
10.1016/S0735-1097(01)01211-6
Electron beam tomography and National Cholesterol Education Program guidelines in asymptomatic women.
H. Hecht (2001)
10.1002/14651858.CD000990.pub4
Exercise for intermittent claudication.
Risha A Lane (2017)
10.1016/S0735-1097(00)01119-0
Correlation of coronary calcification and angiographically documented stenoses in patients with suspected coronary artery disease: results of 1,764 patients.
R. Haberl (2001)
10.1161/CIRCULATIONAHA.111.034884
Birth Characteristics and Subsequent Risks of Maternal Cardiovascular Disease: Effects of Gestational Age and Fetal Growth
A. Bonamy (2011)
10.1136/hrt.2009.188607
The effect of optimal medical therapy on 1-year mortality after acute myocardial infarction
P. Bramlage (2010)
10.1249/MSS.0b013e3181949333
American College of Sports Medicine Position Stand. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults.
J. Donnelly (2009)
10.1007/s10897-011-9474-6
Informed Choice in Direct-to-Consumer Genetic Testing (DTCGT) Websites: A Content Analysis of Benefits, Risks, and Limitations
Amanda R. Singleton (2011)
10.1001/ARCHPSYC.64.10.1153
Panic attacks and risk of incident cardiovascular events among postmenopausal women in the Women's Health Initiative Observational Study.
J. Smoller (2007)
10.1016/j.atherosclerosis.2014.07.022
The effects of coronary artery calcium screening on behavioral modification, risk perception, and medication adherence among asymptomatic adults: a systematic review.
H. Mamudu (2014)
Emerging Risk Factors
D Wormser (2011)
Lipidmodifying therapies and risk of pancreatitis: a meta-analysis
D Preiss (2012)
10.1016/J.AHJ.2010.08.012
Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
A. Cass (2010)
10.1016/0301-5629(96)00036-1
ROC analysis of noninvasive tests for peripheral arterial disease.
J. Lijmer (1996)
10.1136/annrheumdis-2014-205675
Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study
A. Ogdie (2015)
Prevención de factores de riesgo cardiovascular en pacientes con fibrilación auricular
ESC Guidelines on cardiac pacing and cardiac resynchronization therapy
J. Nielsen (2014)
10.1016/J.JPSYCHORES.2010.04.004
Anxiety and risk of incident coronary heart disease : A meta-analysis
A. Roest (2010)
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.
R. Turner (1998)
10.1001/jama.2012.3954
Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate.
K. Matsushita (2012)
10.1006/PMED.2001.0908
Six-month observational study of prompted stair climbing.
J. Kerr (2001)
10.1161/HYPERTENSIONAHA.109.130765
Hypertensive Pregnancy Disorders and Subsequent Cardiovascular Morbidity and Type 2 Diabetes Mellitus in the Mother
J. Lykke (2009)
Alcohol consumption and cardiovascular mortality among U.S
KJ Mukamal (1987)
Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult
J Genest (2009)
Compendium of Physical Activities: a second update of codes and MET
BE Ainsworth (2011)
10.1681/ASN.2006091006
Lipoprotein metabolism and lipid management in chronic kidney disease.
B. C. Kwan (2007)
10.1016/j.pcad.2011.03.006
Exercise therapy in hypertensive cardiovascular disease.
R. Fagard (2011)
10.1001/jama.2010.297
Association of socioeconomic position with health behaviors and mortality.
S. Stringhini (2010)
10.1016/J.EURURO.2006.07.015
Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient.
P. Montorsi (2006)
10.1136/jech.2008.082511
A dictionary of epidemiology
José Leopoldo Ferreira Antunes (2009)
10.1097/HJH.0b013e32832aa6b5
When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal
A. Zanchetti (2009)
10.1093/eurheartj/ehm584
Work stress and coronary heart disease: what are the mechanisms?
T. Chandola (2008)
10.1097/HJR.0b013e3283361dc5
Exercise intolerance in chronic heart failure: mechanisms and therapies. Part I
M. Piepoli (2010)
Barak Zafrir; Italia: Federación Italiana de Cardiología, Salvatore Novo; Kazajistán: Asociación de Cardiólogos de Kazajistán
10.1177/2047487313501093
Alternative models of cardiac rehabilitation: A systematic review
R. Clark (2015)
10.1503/cmaj.091891
Influenza vaccination, pneumococcal vaccination and risk of acute myocardial infarction: matched case–control study
A. Siriwardena (2010)
10.1097/00006842-200109000-00004
Employee Effects of an Educational Program for Managers at an Insurance Company
T. Theorell (2001)
The consumer case for EU legal restrictions on the use of artificial trans-fats in food
(2014)
10.1016/S0140-6736(04)16721-4
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial
H. Diener (2004)
10.1038/oby.2007.36
Effect of obesity on short- and long-term mortality postcoronary revascularization: a meta-analysis.
A. Oreopoulos (2008)
10.1056/nejmoa010746
EFFECTS OF CLOPIDOGREL IN ADDITION TO ASPIRIN IN PATIENTS WITH ACUTE CORONARY SYNDROMES WITHOUT ST-SEGMENT ELEVATION
P. R. R. Ecurrent (2001)
10.1161/01.ATV.12.8.911
Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials.
R. Mensink (1992)
10.18565/cardio.2014.11.87-104
[Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery].
N.V. Pogosova Pogosova (2014)
10.1177/1741826711407705
Survey of physicians’ practices in the control of cardiovascular risk factors: the EURIKA study
J. Dallongeville (2012)
10.3410/f.717982049.793472489
Faculty of 1000 evaluation for Primary prevention of cardiovascular disease with a Mediterranean diet.
M. Fogelholm (2013)
10.1016/S0140-6736(02)11911-8
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies
Prospective Studies Collaboration (2002)
10.1136/bmj.g1903
Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies
R. Chowdhury (2014)
Risk assessment and management of cardiovascular disease in New Zealand.
M. Williams (2003)
10.1136/heart.86.5.516
Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study
S. Stewart (2001)
Long working hours and risk of coronary heart disease and stroke: a systematic review and meta-analysis
M Kivimaki (2015)
10.1590/1516-3180.20151336T2
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
Cássio D Rodrigues (2015)
10.1016/j.addbeh.2013.10.028
A longitudinal study of electronic cigarette users.
J. Etter (2014)
10.1136/hrt.2006.108167
Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC)
M. Woodward (2007)
10.1056/NEJM200105243442108
Medical treatment of peripheral arterial disease and claudication.
W. Hiatt (2001)
10.1038/sj.bdj.2015.122
Physical activity and all-cause mortality across levels of overall and abdominal adiposity in European men and women: the European Prospective Investigation into Cancer and Nutrition Study (EPIC)
U. Ekelund (2015)
10.1016/j.jacc.2014.09.077
The natural course of healthy obesity over 20 years.
Joshua A. Bell (2015)
10.1016/j.jacc.2009.10.057
Alcohol and cardiovascular mortality: common sense and scientific truth.
A. Klatsky (2010)
10.1056/NEJMoa1409312
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.
L. Mauri (2014)
Alcohol-use disorders - preventing the development of hazardous and harmful drinking
R. Fleming (2010)
10.1017/S1368980008004278
Downward trends in the prevalence of childhood overweight in the setting of 12-year school- and community-based programmes.
M. Romon (2009)
10.5603/CJ.a2014.0005
Feasibility of home-based cardiac telerehabilitation: Results of TeleInterMed study.
E. Piotrowicz (2014)
©2015 The European Society of Cardiology. Reservados todos los derechos. Para la obtención de permisos, envía correo electrónico a: journals
Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology
K Pyorala (1994)
World Health Organization. Guidelines for implementation. WHO Framework Convention on Tobacco Control. Articles 5.3, 8-14. Geneva:World Health Organization
(2011)
10.4135/9781452229805.n636
The task force.
S. Kamen (1976)
10.1093/OXFORDJOURNALS.AJE.A009302
Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993.
L. Chambless (1997)
10.1016/S0140-6736(12)61031-9
Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy
I. Lee (2012)
10.1056/NEJMoa1307684
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
B. Scirica (2013)
10.1161/01.CIR.0000099844.31524.05
Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis.
N. Sattar (2003)
10.1097/HJH.0b013e32834f03bf
Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group ‘Hypertension Arrhythmias and Thrombosis’ of the European Society of Hypertension
A. Manolis (2012)
10.1210/jc.2007-0425
Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation.
L. Shaw (2008)
10.1371/journal.pone.0101518
The PlA1/A2 Polymorphism of Glycoprotein IIIa as a Risk Factor for Myocardial Infarction: A Meta-Analysis
C. Floyd (2014)
Vojislav Giga; Suecia: Sociedad Sueca de Cardiología, Anna Kiessling; Suiza: Sociedad Suiza de Cardiología, François Mach; Túnez: Sociedad Tunecina de Cardiología y Cirugía Cardiovascular
ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology
N J Stone (2013)
10.1016/S0895-4356(96)00275-2
The diagnostic value of the measurement of the ankle-brachial systolic pressure index in primary health care.
H. Stoffers (1996)
10.1161/CIRCULATIONAHA.114.013116
Metabolite Profiling and Cardiovascular Event Risk: A Prospective Study of 3 Population-Based Cohorts
Peter Würtz (2015)
10.1016/S0140-6736(98)07019-6
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
UK Prospective Diabetes Study Group (1998)
10.1161/CIRCULATIONAHA.109.852756
Cardiovascular Risk-Estimation Systems in Primary Prevention: Do They Differ? Do They Make a Difference? Can We See the Future?
M. Cooney (2010)
10.1016/j.ijcard.2014.10.011
Cardiac rehabilitation for people with heart disease: an overview of Cochrane systematic reviews.
L. Anderson (2014)
10.1016/j.jacc.2008.05.002
Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Coun
V. Somers (2008)
10.1016/J.AMJCARD.2008.10.002
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia.
J. Fruchart (2008)
10.12923/J.0044-2011/122/3/A.21
The Toronto Charter for Physical Activity: A Global Call for Action.
M. Stelmach (2010)
10.1056/NEJMoa1500858
Efficacy and safety of evolocumab in reducing lipids and cardiovascular events.
M. Sabatine (2015)
10.1002/14651858.cd000165.pub2
Physician advice for smoking cessation.
T. Lancaster (2004)
10.1161/CIRCULATIONAHA.114.014791
Clopidogrel With Aspirin in Acute Minor Stroke or Transient Ischemic Attack (CHANCE) Trial: One-Year Outcomes
Y. Wang (2015)
10.1093/sleep/14.6.540
A new method for measuring daytime sleepiness: the Epworth sleepiness scale.
M. Johns (1991)
10.1371/journal.pmed.1001335
Leisure Time Physical Activity of Moderate to Vigorous Intensity and Mortality: A Large Pooled Cohort Analysis
S. Moore (2012)
10.1097/HJH.0b013e32835d8230
Guidelines on guidelines: focus on isolated systolic hypertension in youth.
M. O'Rourke (2013)
10.1002/14651858.CD009329.pub2
Pharmacological interventions for smoking cessation: an overview and network meta-analysis.
K. Cahill (2013)
E-cigarettes: a scientific review
R Grana (1972)
Writing Group for the DCCT/EDIC
Group (2015)
European Association for Cardiovascular Prevention
Rehabilitation (2011)
10.1093/eurheartj/eht232
Long-term impact on healthcare resource utilization of statin treatment, and its cost effectiveness in the primary prevention of cardiovascular disease: a record linkage study
A. McConnachie (2014)
10.1016/j.amjmed.2008.09.038
Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials.
D. Wald (2009)
10.1136/bmj.e7677
Cardiovascular mortality after pre-eclampsia in one child mothers: prospective, population based cohort study
R. Skjaerven (2012)
10.1016/S0140-6736(14)61183-1
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
D. Swerdlow (2015)
10.1093/eurheartj/ehu458
Expert position paper on air pollution and cardiovascular disease.
D. Newby (2015)
10.1136/heartjnl-2011-301478
Cardiovascular risk age: concepts and practicalities
M. Cooney (2012)
10.1056/NEJMoa1509225
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.
M. Pfeffer (2015)
10.1016/j.medcli.2008.06.025
[Mortality from cardiovascular diseases in immigrants residing in Madrid].
E. Regidor (2009)
10.1177/030089169207800419
Libri Ricevuti: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
T. Dragani (1992)
10.1016/S0140-6736(15)60295-1
Long working hours and risk of coronary heart disease and stroke: a systematic review and meta-analysis of published and unpublished data for 603 838 individuals
M. Kivimäki (2015)
10.1016/j.atherosclerosis.2013.03.033
DNA methylation variations at CETP and LPL gene promoter loci: new molecular biomarkers associated with blood lipid profile variability.
S. Guay (2013)
10.1136/bmj.38875.675486.55
A meta-analysis of the association between adherence to drug therapy and mortality
S. Simpson (2006)
10.1097/01.hjh.0000226212.34055.86
Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial
H. Arima (2006)
10.1056/NEJMOA060989
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.
Deepak L. Bhatt (2006)
A review of research into the impacts of alcohol warning labels on attitudes and behaviour. British Colombia, Canada: Center for Addiction
T. Stockwell (2006)
10.1016/j.jacc.2009.07.020
Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians.
M. Cooney (2009)
10.1016/j.ijcard.2012.10.049
Short-term outcome and attainment of secondary prevention goals in patients with acute coronary syndrome--results from the countrywide TARGET study.
G. Andrikopoulos (2013)
10.1161/01.STR.31.6.1240
Indications for early aspirin use in acute ischemic stroke : A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups.
Z. Chen (2000)
10.1016/S0167-5273(00)00449-6
Comparison of spiral and electron beam tomography in the evaluation of coronary calcification in asymptomatic persons.
M. Budoff (2001)
10.1186/1471-2458-11-554
Cardiovascular disease by diabetes status in five ethnic minority groups compared to ethnic Norwegians
A. T. Tran (2011)
10.1016/j.jdiacomp.2014.02.011
Lessons from SAVOR and EXAMINE: some important answers, but many open questions.
G. Schernthaner (2014)
10.1161/CIRCOUTCOMES.108.812859
Stress Reduction Prolongs Life in Women With Coronary Disease: The Stockholm Women’s Intervention Trial for Coronary Heart Disease (SWITCHD)
K. Orth-Gomér (2009)
10.1016/S0140-6736(10)60484-9
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
The Emerging Risk Factors Collaboration (2010)
Long-term cost and life-expectancy consequences of hypertension.
F. O. Simpson (1998)
10.1016/j.amjcard.2012.05.028
Effect of nicotine replacement therapy on cardiovascular outcomes after acute coronary syndromes.
Kevin J Woolf (2012)
10.1161/CIRCULATIONAHA.113.007252
Discontinuation of Smokeless Tobacco and Mortality Risk After Myocardial Infarction
G. Arefalk (2014)
10.1081/PRG-100100136
LONG-TERM PROGNOSIS OF HYPERTENSION IN PREGNANCY
R. Marín (2000)
10.1161/RES.0b013e31824da8ad
Minimal and null predictive effects for the most popular blood biomarkers of cardiovascular disease.
J. Ioannidis (2012)
Sociedad Libanesa de Cardiología, Georges Saade; Lituania: Sociedad Lituana de Cardiología, Zaneta Petrulioniene; Luxemburgo: Sociedad de Cardiología de Luxemburgo
Líbano
Rapid bloodpressure lowering in patients with acute intracerebral hemorrhage
C S Anderson (2013)
Alcohol consumption and cardiovascular mortality among U.S. adults
K J Mukamal (1987)
10.1136/bmj.g4490
Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies
Xia Wang (2014)
10.1016/S0140-6736(98)04311-6
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
L. Hansson (1998)
10.1136/hrt.2010.210740
Family history of premature coronary heart disease and risk prediction in the EPIC-Norfolk prospective population study
S. Sivapalaratnam (2010)
10.1016/S0140-6736(14)61730-X
Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials
J. Mega (2015)
10.1136/heartjnl-2013-303989
Effect of a nurse-coordinated prevention programme on cardiovascular risk after an acute coronary syndrome: main results of the RESPONSE randomised trial
H. Jørstad (2013)
10.1136/jech.54.5.328
The relation between alcohol and cardiovascular disease in Eastern Europe: explaining the paradox
A. Britton (2000)
10.1177/2047487314543075
Psychosocial aspects in cardiac rehabilitation: From theory to practice. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation of the European Society of Cardiology
N. Pogosova (2015)
10.1002/art.34524
Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease.
A. Semb (2012)
Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group.
F. Sacks (2001)
10.1136/bmj.39609.449676.25
Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2
J. Hippisley-Cox (2008)
10.1001/jamainternmed.2013.3018
Bias in associations of emerging biomarkers with cardiovascular disease.
I. Tzoulaki (2013)
10.1093/eurpub/ckt023
Sizable variations in circulatory disease mortality by region and country of birth in six European countries.
S. Rafnsson (2013)
Efficacy of cholesterollowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a metaanalysis
P M Kearney (2008)
Consensus Statement of the European Atherosclerosis Society
B. Nordestgaard
10.1097/HJR.0b013e3283313592
Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation
M. Piepoli (2010)
10.1007/s12529-012-9242-5
European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012)
J. Perk (2012)
Blood Pressure Lowering Treatment Trialists
F Turnbull (2008)
Multislice computed tomography coronary angiography for risk stratification in patients
JM van Werkhoven (2009)
Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a metaanalysis
FG Fowkes (2008)
10.7326/0003-4819-136-12-200206180-00008
The Ankle Brachial Index Is Associated with Leg Function and Physical Activity: The Walking and Leg Circulation Study
M. McDermott (2002)
10.1097/01.hjr.0000129739.30593.23
No long-term psychological reaction to information about increased risk of coronary heart disease in general practice
B. Christensen (2004)
10.1016/S0140-6736(06)68069-0
Fruit and vegetable consumption and stroke: meta-analysis of cohort studies
F. He (2006)
10.1097/01.hjh.0000249693.73618.c9
Prevalence and management of hypertension among Turkish, Moroccan and native Dutch ethnic groups in Amsterdam, the Netherlands: the Amsterdam Health Monitor Survey
C. Agyemang (2006)
10.1056/nejm200511033531819
Adherence to medication.
A. Lippman (2005)
10.1136/bmj.37938.645220.EE
Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH)
M. Piepoli (2004)
10.1371/journal.pone.0041842
Which Interventions Offer Best Value for Money in Primary Prevention of Cardiovascular Disease?
L. Cobiac (2012)
10.1161/CIRCHEARTFAILURE.112.969246
Markers of Decongestion, Dyspnea Relief, and Clinical Outcomes Among Patients Hospitalized With Acute Heart Failure
R. Kociol (2013)
Guideline: Sugars Intake for Adults and Children. Geneva: World Health Organization
(2015)
European Heart Network. Diet, Physical Activity and Cardiovascular Disease Prevention in Europe
(2011)
10.3945/ajcn.113.076109
Nut consumption and risk of type 2 diabetes, cardiovascular disease, and all-cause mortality: a systematic review and meta-analysis.
C. Luo (2014)
10.1056/NEJMoa0801369
Treatment of hypertension in patients 80 years of age or older.
N. Beckett (2008)
10.1016/j.atherosclerosis.2010.09.014
Physicians' perception, knowledge and awareness of cardiovascular risk factors and adherence to prevention guidelines: the PERCRO-DOC survey.
Ž. Reiner (2010)
10.1016/j.jacc.2012.06.043
A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation).
B. Kim (2012)
10.7326/M14-1430
Cost-Effectiveness and Population Impact of Statins for Primary Prevention in Adults Aged 75 Years or Older in the United States
M. Odden (2015)
10.1111/j.1742-1241.2012.02908.x
A review of family history of cardiovascular disease: risk factor and research tool
A. Banerjee (2012)
10.1093/eurheartj/ehs210
Cost-effectiveness of optimizing prevention in patients with coronary heart disease: the EUROASPIRE III health economics project.
D. De Smedt (2012)
10.1001/jama.2013.282183
Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial.
F. Feres (2013)
10.1093/eurheartj/eht112
Erectile dysfunction in the cardiovascular patient.
C. Vlachopoulos (2013)
10.1371/journal.pone.0084445
A Cost Effectiveness Analysis of Salt Reduction Policies to Reduce Coronary Heart Disease in Four Eastern Mediterranean Countries
H. Mason (2014)
10.1016/S0140-6736(10)62037-5
National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants
Mariel M. Finucane (2011)
10.1016/S0140-6736(10)60674-5
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
Chronic Kidney Disease Prognosis Consortium (2010)
10.1016/S0140-6736(10)62296-9
Public health importance of triggers of myocardial infarction: a comparative risk assessment
T. Nawrot (2011)
10.1016/J.REC.2011.11.006
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
C. Hamm (2012)
10.1016/S0140-6736(11)60105-0
Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies
The Emerging Risk Factors Collaboration (2011)
10.1016/j.ijcard.2014.11.107
Challenges in secondary prevention of cardiovascular diseases: a review of the current practice.
M. Piepoli (2015)
Long-term complications and mortality in youngonset diabetes: type 2 diabetes is more hazardous and lethal than type 1 diabetes
MI Constantino (2013)
The high-density lipoproteinadjusted SCORE model worsens SCORE-based risk classification in a contemporary population of 30,824 Europeans: the Copenhagen General Population Study
MB Mortensen (2015)
Compliance, safety, and effectiveness of fixeddose combinations of antihypertensive agents: a meta-analysis. Hypertension
AK Gupta (2010)
Emerging Risk Factors
E Di Angelantonio (2015)
10.1097/PSY.0b013e3181d01611
Lack of Social Support in the Etiology and the Prognosis of Coronary Heart Disease: A Systematic Review and Meta-Analysis
J. Barth (2010)
10.1097/HJR.0b013e3283383f30
EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries
K. Kotseva (2010)
European cardiovascular disease statistics
S. Allender (2008)
10.1056/NEJMoa0805002
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke.
R. Sacco (2008)
10.1016/S0140-6736(05)67394-1
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.
C. Baigent (2005)
10.1161/CIRCOUTCOMES.108.831198
C-Reactive Protein and Reclassification of Cardiovascular Risk in the Framingham Heart Study
P. Wilson (2008)
10.1097/HJH.0b013e328364ca4c
2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension.
G. Mancia (2013)
10.1161/CIR.0000000000000019
Depression as a Risk Factor for Poor Prognosis Among Patients With Acute Coronary Syndrome: Systematic Review and Recommendations A Scientific Statement From the American Heart Association
J. Lichtman (2014)
10.1073/PNAS.0400266101
Cardiovascular fitness, cortical plasticity, and aging.
S. Colcombe (2004)
ANEXO WEB En este epígrafe se recoge el anexo web
NICE Public Health Guidance 25. Prevention of Cardiovascular Disease
Aspirin to Reduce Risk of Initial Vascular Events
10.1249/MSS.0b013e318213fefb
American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise.
C. Garber (2011)
10.1016/J.MATURITAS.2006.11.004
Age at menopause and cause-specific mortality in South Korean women: Kangwha Cohort Study.
J. Hong (2007)
10.7326/0003-4819-159-11-201312030-00008
Are Metabolically Healthy Overweight and Obesity Benign Conditions?
C. Kramer (2013)
10.1161/01.HYP.0000121223.44837.de
Left Ventricular Concentric Geometry During Treatment Adversely Affects Cardiovascular Prognosis in Hypertensive Patients
M. Muiesan (2004)
10.1093/ANNONC/MDF132
Functional monitoring of anthracycline cardiotoxicity: a prospective, blinded, long-term observational study of outcome in 120 patients.
B. V. Jensen (2002)
10.1001/archinternmed.2011.399
Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials.
V. Santschi (2011)
10.1016/S0140-6736(05)67528-9
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial
J. Dormandy (2005)
10.1016/j.jacc.2010.10.047
Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials.
D. Waters (2011)
10.1055/s-0033-1360102
[Psychocardiology: clinically relevant recommendations regarding selected cardiovascular diseases].
C. Albus (2014)
10.1161/CIRCULATIONAHA.109.865600
Mortality and Vascular Morbidity in Older Adults With Asymptomatic Versus Symptomatic Peripheral Artery Disease
C. Diehm (2009)
10.1016/S0828-282X(09)70715-9
2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations.
J. Genest (2009)
Document downloaded from http://www.revespcardiol.org/, day 11/07/2019. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited
JS (2012)
Reservados todos los derechos. Para la obtención de permisos, envía correo electrónico a: journals.permissions@oup.com 7. BIBLIOGRAFÍA 1. A Dictionary of Epidemiology
10.1056/NEJM199612123352402
The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease.
A. Joseph (1996)
10.1056/NEJMoa0808431
Glucose control and vascular complications in veterans with type 2 diabetes.
W. Duckworth (2009)
10.1016/j.jacc.2014.08.021
A polypill strategy to improve adherence: results from the FOCUS project.
J. Castellano (2014)
10.1016/j.ihj.2013.08.003
Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies. The OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of
M. Bansal (2013)
10.1056/NEJMc1415677
Glycemic control and excess mortality in type 1 diabetes.
D. Magliano (2015)
10.1016/J.AHJ.2004.10.015
Effects of a psychosocial skills training workshop on psychophysiological and psychosocial risk in patients undergoing coronary artery bypass grafting.
G. Bishop (2005)
10.1001/jama.2012.9630
Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis.
H. D. den Ruijter (2012)
10.1001/ARCHINTE.166.17.1855
Physician communication when prescribing new medications.
D. M. Tarn (2006)
10.1002/ejhf.156
Cardiopulmonary exercise testing in systolic heart failure in 2014: the evolving prognostic role
U. Corrà (2014)
10.1207/S15327558IJBM0903_05
Women’s hearts need special treatment
G. Burell (2002)
10.1097/HCR.0000000000000034
Psychosocial Benefits of Cardiac Rehabilitation Among Women Compared With Men
Garrett Hazelton (2014)
ACSM's Guidelines for Exercise Testing and Prescription
L. Pescatello (1995)
10.1093/ntr/ntq044
A cross-national comparative study of smoking prevalence and cessation between English and Dutch South Asian and African origin populations: the role of national context.
C. Agyemang (2010)
10.1001/ARCHINTE.165.21.2508
Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study.
A. Gehi (2005)
10.1177/2047487312446562
Palpitations are predictive of future atrial fibrillation. An 11-year follow-up of 22,815 men and women: the Tromsø Study
A. Nyrnes (2013)
10.1093/eurjhf/hfs048
Adherence of heart failure patients to exercise: barriers and possible solutions
V. Conraads (2012)
10.1093/eurheartj/eht273
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease
B. Nordestgaard (2013)
10.1016/J.ACCREVIEW.2004.11.066
Global risk scores and exercise testing for predicting all-cause mortality in a preventive medicine program.
M. K. Aktas (2004)
10.1016/J.ATHEROSCLEROSIS.2005.06.005
Impact of migration on coronary heart disease risk factors: comparison of Gujaratis in Britain and their contemporaries in villages of origin in India.
Jeetesh V. Patel (2006)
10.1161/circulationaha.107.748095
Efficacy of In-Hospital Multidimensional Interventions of Secondary Prevention After Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
R. Auer (2008)
10.1136/bmj.d636
Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies
Susan E. Brien (2011)
10.1161/CIRCULATIONAHA.108.768986
Medication Adherence: Its Importance in Cardiovascular Outcomes
P. Ho (2009)
10.1111/j.1471-0528.2009.02448.x
Preterm delivery and risk of subsequent cardiovascular morbidity and type‐II diabetes in the mother
J. Lykke (2010)
10.1097/HJR.0b013e328334f42d
Cardiac rehabilitation in Europe: results from the European Cardiac Rehabilitation Inventory Survey
B. Bjarnason-Wehrens (2010)
10.1001/jama.2014.14781
Wearable devices as facilitators, not drivers, of health behavior change.
M. Patel (2015)
10.1016/S0140-6736(06)69251-9
Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies
A. Romero‐Corral (2006)
10.1016/j.jacc.2013.11.004
2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society.
M. Jensen (2014)
10.1093/EUROPACE/EUS305
2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association.
A. Camm (2012)
Document downloaded from http://www.revespcardiol.org/, day 10/03/2020. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited
AL Culver (2012)
10.1136/bmj.f1378
Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses
N. J. Aburto (2013)
10.1373/clinchem.2011.165712
Biomarkers and cardiovascular risk assessment for primary prevention: an update.
Lauren G Gilstrap (2012)
10.1097/HJR.0b013e3283213140
How much does HDL cholesterol add to risk estimation? A report from the SCORE investigators
M. Cooney (2009)
10.1161/CIRCGENETICS.112.964148
Clinical utility of genetic variants for cardiovascular risk prediction: a futile exercise or insufficient data?
E. Di Angelantonio (2012)
Low-dose aspirin for primary prevention of ardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial
Y Ikeda (2014)
10.3399/bjgp11X561249
Are physical activity interventions in primary care and the community cost-effective? A systematic review of the evidence.
Sue Garrett (2011)
Motivational interviewing: a systematic review and meta-analysis.
S. Rubak (2005)
10.1056/NEJMp1106688
Fibrates in the treatment of dyslipidemias--time for a reassessment.
A. Goldfine (2011)
10.1056/NEJMoa1410489
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.
C. Cannon (2015)
10.1016/j.jnn.2010.11.006
National Institute for Health and Clinical Excellence
A. Dhar (2005)
10.1038/nrcardio.2009.223
Effects of cardiac rehabilitation referral strategies on referral and enrollment rates
Shannon Gravely-Witte (2010)
10.1002/14651858.CD007131.pub3
Promoting patient uptake and adherence in cardiac rehabilitation.
Kunal N. Karmali (2014)
10.1016/j.ejca.2013.04.030
Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: a systematic review and meta-analysis.
K. Kalam (2013)
10.1136/bmj.326.7380.84
Secondary prevention clinics for coronary heart disease: four year follow up of a randomised controlled trial in primary care
P. Murchie (2003)
Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack
S. MacMahon (2001)
10.1016/J.JACC.2005.05.085
Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis.
J. Robinson (2005)
10.1002/14651858.cd003331
Exercise based rehabilitation for heart failure.
K. Rees (2004)
World Health Organization. Familial hypercholesterolemia-report of a secondWHO consultation. Geneva: World Health Organization
(1999)
10.1046/J.1360-0443.1999.94811253.X
Privatizing alcohol sales and alcohol consumption: evidence and implications.
M. Her (1999)
10.1177/1741826711430926
Importance of characteristics and modalities of physical activity and exercise in the management of cardiovascular health in individuals with cardiovascular risk factors: recommendations from the EACPR (Part II)
L. Vanhees (2012)
10.1136/bmjopen-2013-002837
Modelling the impact of specific food policy options on coronary heart disease and stroke deaths in Ireland
C. O'Keeffe (2013)
10.1371/journal.pone.0065130
Socioeconomic Status, Functional Recovery, and Long-Term Mortality among Patients Surviving Acute Myocardial Infarction
D. Alter (2014)
10.1007/s00125-012-2510-8
HbA1c in type 2 diabetes diagnostic criteria: addressing the right questions to move the field forwards
N. Sattar (2012)
10.1002/14651858.CD000248
Anticoagulants for preventing recurrence following ischaemic stroke or transient ischaemic attack.
M. Liu (2000)
10.1093/aje/kwp377
Genetic variants identified in a European genome-wide association study that were found to predict incident coronary heart disease in the atherosclerosis risk in communities study.
J. Bressler (2010)
10.1097/PSY.0b013e3180f62357
Marital Status, Marital Strain, and Risk of Coronary Heart Disease or Total Mortality: The Framingham Offspring Study
E. Eaker (2007)
10.1136/bmj.309.6959.901
Mortality in relation to smoking: 40 years' observations on male British doctors
R. Doll (1994)
10.3205/000194
Position paper on the importance of psychosocial factors in cardiology: Update 2013
K. Ladwig (2014)
Cholesterol Treatment Trialists
JR Emberson (2012)
10.1093/eurheartj/ehu523
ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting.
Stefanie Schulz-Schüpke (2015)
10.1002/14651858.cd000031.pub3
Antidepressants for smoking cessation.
J. Hughes (2000)
10.1016/j.psym.2013.09.002
Essential articles on collaborative care models for the treatment of psychiatric disorders in medical settings: a publication by the academy of psychosomatic medicine research and evidence-based practice committee.
J. Huffman (2014)
10.1097/HJR.0b013e328157f3e5
CUORE: a sustainable cardiovascular disease prevention strategy
S. Giampaoli (2007)
Action to Control Cardiovascular Risk in Diabetes
M. Özkaya (2013)
Blood Pressure Lowering Treatment Trialists
J Sundstrom (2014)
All-cause mortality risk of metabolically healthy abdominal obese individuals: the EPICMORGEN study. Obesity
AD van der (2014)
Measurement of blood pressure in the office: recognizing the problem and proposing the solution. Hypertension
MG Myers (2010)
A Survey of GPs Awareness and Use of Risk Assessment Tools and Cardiovascular Disease Prevention Guidelines.
D. Byrne (2015)
10.1161/CIR.0b013e31829b5b44
Exercise standards for testing and training: a scientific statement from the American Heart Association.
G. Fletcher (2013)
10.1016/S2213-8587(15)00232-6
Postnatal testing following gestational diabetes: time to replace the oral glucose tolerance test?
Hema Venkataraman (2015)
10.1056/NEJMoa1214234
Cystatin C versus creatinine in determining risk based on kidney function.
M. Shlipak (2013)
10.1001/jama.2012.9624
Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals.
J. Yeboah (2012)
10.1161/CIRCULATIONAHA.107.711507
Age-Dependent Associations Between Chronic Periodontitis/Edentulism and Risk of Coronary Heart Disease
T. Dietrich (2008)
10.1161/CIRCULATIONAHA.114.014310
Prevalence, Vascular Distribution, and Multiterritorial Extent of Subclinical Atherosclerosis in a Middle-Aged Cohort: The PESA (Progression of Early Subclinical Atherosclerosis) Study
L. Fernandez-Friera (2015)
10.2337/dc14-2441
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
S. Inzucchi (2014)
10.1016/S0140-6736(10)61267-6
A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses
S. Ripatti (2010)
10.1136/bmjopen-2013-003415
Myocardial infarction incidence and survival by ethnic group: Scottish Health and Ethnicity Linkage retrospective cohort study
N. Bansal (2013)
10.1161/CIRCULATIONAHA.111.035725
Integrating information from novel risk factors with calculated risks: the critical impact of risk factor prevalence.
A. J. Kooter (2011)
10.1136/hrt.2009.167353
Multislice computed tomography coronary angiography for risk stratification in patients with an intermediate pretest likelihood
J. M. van Werkhoven (2009)
10.1136/hrt.2008.150979
Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease
J. Robson (2008)
10.1136/hrt.2008.153353
Clinical characteristics of patients with obstructive coronary lesions in the absence of coronary calcification: an evaluation by coronary CT angiography
M. Marwan (2009)
10.1056/NEJMOA020233
Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.
A. Maisel (2002)
10.1097/HJH.0b013e328308da66
European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring
G. Parati (2008)
Effects of an angiotensinconverting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators
S Yusuf (2000)
Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the
G Saposnik (2011)
10.1016/j.jacc.2012.04.040
Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: results from the UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy) study.
J. Blumenthal (2012)
10.1016/j.jacc.2008.10.024
Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk.
J. Robinson (2009)
Cholesterol Treatment Trialists
C Baigent (2010)
10.1161/CIRCULATIONAHA.106.660043
Impact of Traditional and Novel Risk Factors on the Relationship Between Socioeconomic Status and Incident Cardiovascular Events
M. Albert (2006)
10.1136/bmj.316.7137.1043
Smoking and risk of myocardial infarction in women and men: longitudinal population study
E. Prescott (1998)
10.1177/2047487314551538
Coronary heart disease incidence among non-Western immigrants compared to Danish-born people: effect of country of birth, migrant status, and income
A. Bø (2015)
10.2165/00151234-200705380-00004
2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension
(2007)
10.1093/eurheartj/ehq236
Secondary prevention through cardiac rehabilitation: physical activity counselling and exercise training: key components of the position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation.
U. Corrá (2010)
10.1136/bmj.39548.738368.BE
Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials
F. Turnbull (2008)
10.1016/S0140-6736(13)61842-5
Electronic cigarettes for smoking cessation: a randomised controlled trial
Christopher Bullen (2013)
10.1136/bmj.38142.554479.AE
Mortality in relation to smoking: 50 years' observations on male British doctors
R. Doll (2004)



This paper is referenced by
10.1016/j.atherosclerosis.2017.12.027
The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation.
G. Martínez (2018)
10.1016/j.arteri.2018.09.001
Relation between serum uric acid levels with the degree of coronary artery disease: A prospective study from Ecuador.
Maria Egas-Izquierdo (2019)
10.1016/J.IJCAC.2017.05.009
The preference of the physicians in diagnosis and treatment of cardiovascular diseases
Lütfü Bekar (2017)
Riesgo cardiovascular global en una población adulta mayor del área rural, Cantón de Garabito, Puntarenas (Global cardiovascular risk on an elderly population in a rural area in Garabito, Puntarenas, Costa Rica)
Pablo Vásquez-Carrillo (2015)
10.1186/s12884-020-2753-1
Lipid profiling in maternal and fetal circulations in preeclampsia and fetal growth restriction-a prospective case control observational study
T. I. Alahakoon (2020)
10.1016/j.jneb.2018.06.003
Efficacy of Cognitive Behavioral Therapy in Adherence to the Mediterranean Diet in Metabolic Syndrome Patients: A Randomized Controlled Trial
Jaqueline Garcia-Silva (2018)
10.1016/J.RECESP.2018.08.014
Asociación del consumo máximo de oxígeno con la actividad física y el sedentarismo en el síndrome metabólico. Utilidad de los cuestionarios
Lucas Tojal (2020)
10.1016/j.ajpc.2020.100003
Ten Things to Know About Ten Cardiovascular Disease Risk Factors (“ASPC Top Ten – 2020”)
H. Bays (2020)
10.1111/jch.13812
Association of pulse wave velocity and intima‐media thickness with cardiovascular risk factors in young adults
M. Cecelja (2020)
10.1186/s12875-018-0849-8
Characteristics of patients with acute myocardial infarction contacting primary healthcare before hospitalisation: a cross-sectional study
Per O Andersson (2018)
10.15406/jccr.2019.12.00420
Evaluation of cardiovascular risk according to Framingham tables in a Colombian population
Pereira-rodriguez Javier Eliecer (2018)
10.1016/J.MED.2017.06.001
Insuficiencia cardíaca. Generalidades
J. S. Castillo (2017)
10.1016/S1131-3587(19)30012-3
Importancia de la medicina traslacional: mecanismos del beneficio del tratamiento de las dislipemias y su implicación en la reducción de la placa
Mónica Doménech (2017)
10.1016/J.HIPERT.2019.01.001
Principales conclusiones del Consenso Argentino de Hipertensión Arterial
A. Delucchi (2019)
Algoritmo de actuación en la farmacia comunitaria para optimizar la utilización de estatinas
F. F. Estrela (2015)
10.1016/j.endien.2019.04.006
The prevalence and risk factors associated with dyslipidemia in type 2 diabetic patients in the autonomous Region of Cantabria.
Alcibíades Segundo Díaz Vera (2020)
10.1016/J.ENDINU.2019.04.010
Prevalencia y factores de riesgo asociados a la dislipidemia en pacientes diabéticos tipo 2 de la Comunidad de Cantabria
Alcibíades Segundo Díaz Vera (2020)
10.1016/J.RCCAR.2018.05.012
Prevención secundaria tras un síndrome coronario agudo. Resultados a medio plazo de un programa de rehabilitación cardiaca
Maruan C. Chabbar Boudet (2019)
10.1016/j.rec.2018.08.027
Association Between Maximal Oxygen Consumption and Physical Activity and Sedentary Lifestyle in Metabolic Syndrome. Usefulness of Questionnaires.
Lucas Tojal (2018)
10.1016/J.RCCAR.2018.09.002
Consenso de expertos sobre el manejo clínico de la hipertensión arterial en Colombia. Sociedad Colombiana de Cardiología y Cirugía
L. Moya (2018)
10.1016/j.jpsychores.2018.10.005
Type D personality affects health-related quality of life in patients with lone atrial fibrillation by increasing symptoms related to sympathetic activation.
Nina Kupper (2018)
10.1186/s12955-018-1008-6
Physical activity, cardiovascular health, quality of life and blood pressure control in hypertensive subjects: randomized clinical trial
V. Arija (2018)
10.3390/nu11122863
Interactions between DRD2/ANKK1 TaqIA Polymorphism and Dietary Factors Influence Plasma Triglyceride Concentrations in Diabetic Patients from Western Mexico: A Cross-sectional Study
O. Ramos-Lopez (2019)
10.1038/s41598-018-34468-7
Association of domain-specific physical activity and cardiorespiratory fitness with all-cause and cause-specific mortality in two population-based cohort studies
M. Bahls (2018)
10.1016/J.MED.2017.10.003
Tratamiento de los factores de riesgo cardiovascular
Maria Luisa Sánchez-Montes (2017)
10.3233/BMR-170847
Musculoskeletal pain and related factors in coronary artery disease: An observational cross-sectional study.
Didem Sezgin Ozcan (2018)
10.1016/J.RCE.2017.12.004
Propuesta de una escala clínica para el diagnóstico de síndrome coronario agudo en pacientes con electrocardiograma y biomarcadores de lesión miocárdica no concluyentes
F. J. Montero-Pérez (2018)
10.1007/s12928-020-00655-5
Stent edge vascular response and in-stent geometry after aerobic exercise
Maria Dalen Taraldsen (2020)
10.1016/j.rec.2019.08.012
Recommendations to improve lipid control. Consensus document of the Spanish Society of Cardiology.
C. Escobar (2019)
10.1024/0301-1526/a000798
Real-world outcomes of endovascular treatment in a non-selected population with peripheral artery disease - prospective study with 2-year follow-up.
Karl-Ludwig Schulte (2019)
10.1016/J.MED.2017.06.010
Cardiopatía isquémica: concepto, clasificación, epidemiología, factores de riesgo, pronóstico y prevención
J. E. Alcalá López (2017)
10.1186/s12884-020-2769-6
Implementing a healthy postpartum lifestyle after gestational diabetes or preeclampsia: a qualitative study of the partner’s role
Ingfrid Almli (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar